In an apparent case of first impression, a Philadelphia judge ruled that a medical publications company involved in clinical research did not owe a duty of care to plaintiffs who used the antipsychotic drug Risperdal.
No Duty Found for Med. Publisher in Risperdal Mass Tort
The Legal Intelligencer
July 9, 2013